South Africa: North Gauteng High Court, Pretoria Support SAFLII

You are here:  SAFLII >> Databases >> South Africa: North Gauteng High Court, Pretoria >> 2022 >> [2022] ZAGPPHC 584

| Noteup | LawCite

Teva Pharmaceutical Industries Limited v Novartis AG (47958/2021) [2022] ZAGPPHC 584 (3 August 2022)

Download original files

PDF format

RTF format


 

IN THE HIGH COURT OF SOUTH AFRICA

GAUTENG DIVISION, PRETORIA

 

CASE NO: 47958/2021

PATENT NO: 2012/01678

REPORTABLE: NO

OF INTEREST TO OTHER JUDGES: NO

REVISED

3 August 2022

 

In the matter between:

TEVA PHARMACEUTICAL INDUSTRIES LIMITED                       Opponent/Applicant

and

NOVARTIS AG                                                                                 Patentee/Respondent

 

JUDGMENT

 

RAULINGA J

1.            This matter was called before me on 30 May 2022, and by agreement between the parties was rolled over to 1 June 2022.

2.            On 1 June 2022 after hearing argument by counsel for the parties, judgment was reserved.

3.            The applicant sought that issues be separated and adjudicated prior to any other issues in dispute in the opposition.

4.            That the opposition be stayed until the separated issues have been determined.

5.            Having perused the papers and after hearing counsel for the parties, I make the following order:

5.1 The application is dismissed with costs.

 

 

T. J RAULINGA

JUDGE OF THE HIGH COURT

 

 

Appearances

Applicant’s Counsel                                                : ADV C Puckrin SC

: ADV K Lles

Applicant’s Attorneys                                              : Webber Wentzel Attorneys

Respondent’s Counsel                                           : ADV G Marriott

Respondent’s Attorney                                           : Adams & Adams Attorney

Date of hearing                    : 01 June 2022

Date of judgment                 : 03 August 2022